Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)

Radiation Oncology

Volumn 4, Issue , 2009, Pages

  Loong, Susan Li Er ^a   Hwang, Jacqueline Siok Gek ^b   Li, Hui Hua ^a   Wee, Joseph Tien Seng ^a   Yap, Swee Peng ^a   Chua, Melvin Lee Kiang ^a   Fong, Kam Weng ^a   Tan, Terence Wee Kiat ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOOXYGENASE 2; FLUOROURACIL; ANTINEOPLASTIC AGENT; PTGS2 PROTEIN, HUMAN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT RESPONSE; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; ENZYMOLOGY; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; PHASE 3 CLINICAL TRIAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE III AS TOPIC; COMBINED MODALITY THERAPY; CYCLOOXYGENASE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68349097303     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-4-23     Document Type: Article

References (17)

1. Hughes PJ Scott PM Kew J Cheung DM Leung SF Ahuja AT van Hasselt CA Dysphagia in treated nasopharyngeal cancer Head Neck 2000, 22:393-7. 10.1002/1097-0347(200007)22:4<393::AID-HED13>3.0.CO;2-2 10862024
2. Chambers MS Rosenthal DI Weber RS Radiation-induced xerostomia Head Neck 2007, 29:58-63. 10.1002/hed.20456 16906511
3. Matsubayashi H Infante JR Winter J Klein AP Schulick R Hruban R Visavanathan K Goggins M Tumour COX-2 expression and prognosis of patients with resectable pancreatic cancer Cancer Biol Ther 2007, 6:1569-75. 18000398
4. Nozoe T Ezaki T Kabashima A Baba H Maehara Y Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus Am J Surg 2005, 189:110-5. 10.1016/ j.amjsurg.2004.03.019 15701502
5. Sackett MK Bairati I Meyer F Jobin E Lussier S Fortin A Gélinas M Nabid A Brochet F Têtu B Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer Clin Cancer Res 2008, 14:67-73. 10.1158/1078-0432.CCR-07-2028 18172254
6. Haffty BG Yang Q Moran MS Tan AR Reiss M Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation Int J Radiat Oncol Biol Phys 2008, 71:1006-13. 18262731
7. Wee J Tan EH Tai BC Wong HB Leong SS Tan T Chua ET Yang E Lee KM Fong KW Tan HS Lee KS Loong S Sethi V Chua EJ Machin D Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/ International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 2005, 23:6730-8. 10.1200/ JCO.2005.16.790 16170180
8. Chan CM Ma BB Hui EP Wong SC Mo FK Leung SF Kam MK Chan AT Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma-a prognostic evaluation and correlation with hypoxia inducible factor-1alpha and vascular endothelial growth factor Oral Oncol 2007, 43:373-8. 10.1016/j.oraloncology.2006.04.004 16979927
9. Chen WC McBride WH Chen SM Lee KF Hwang TZ Jung SM Shau H Liao SK Hong JH Chen MF Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: Clinical and in vitro studies Head Neck 2005, 27:503-12. 10.1002/hed.20178 15772955
10. Greene FL Page DL Fleming ID Fritz AG Balch CM Haller DG Morrow M editors American Joint Committee on Cancer AJCC cancer staging manual New York: Springer 6 2002.
11. Soo R Putti TC Tao Q Goh BC Lee KH Kwok-Seng L Tan L Hsieh WS Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression Arch Otolaryngol Head Neck Surg 2005, 131:147-52. 10.1001/archotol.131.2.147 15723947
12. Tan KB Putti TC Cyclooxygenase-2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications J Clin Pathol 2005, 58:535-8. 1770665 15858127 10.1136/jcp.2004.021923
13. de Heer P Gosens MJ de Bruin EC Dekker-Ensink NG Putter H Marijnen CA Brule van den AJ van Krieken JH Rutten HJ Kuppen PJ Velde van de CJ Dutch Colorectal Cancer Group Cyclooxygenase-2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy Clin Cancer Res 2007, 13:2955-60. 10.1158/ 1078-0432.CCR-06-2042 17504996
14. Khor LY Bae K Pollack A Hammond ME Grignon DJ Venkatesan VM Rosenthal SA Ritter MA Sandler HM Hanks GE Shipley WU Dicker AP COX-2 expression predicts prostate-cancer outcome: Analysis of data from RTOG 92-02 trial Lancet Oncol 2007, 8:912-20. 2080621 17881290 10.1016/ S1470-2045(07)70280-2
15. Cervello M Montalto G Cyclooxygenases in hepatocellular carcinoma World J Gastroenterol 2006, 12:5113-21. 16937518
16. Bae SH Jung ES Park YM Kim BS Kim BK Kim DG Ryu WS Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398 Clin Cancer Res 2001, 7:1410-8. 11350912
17. Trifan OC Smith RM Thompson BD Hla T Overexpression of cyclooxygenase-2 induces cell cycle arrest: Evidence for a prostaglandin-independent mechanism J Biol Chem 1999, 274:34141-7. 10.1074/jbc.274.48.34141 10567385